Many : Actualité Many en direct - P6 | Bourse Reflex
Accueil > Tags > Many

  • Toutes les actualités en rapport avec « Many »

07/12 07:00 Many - The civilian market shows strong interest in the airborne drone: Unmanned Aerial Vehicle (UAV) IT180

07/12 07:00 Many - The civilian market shows strong interest in the IT180 airborne drone

20/11 16:30 Many - Auplata receives approval to proceed with construction of processing plant in Prefect of French Guiana

18/11 21:40 Many - Artprice obtains innovative company investment status

11/11 17:35 Many - Artprice's Annual Report on the Art Photography Market for Paris Photo

27/10 18:00 Many - Abandonment of merger project with Nova Power

05/10 19:30 Many - Artprice's 2014/15 Contemporary Art Market Report: +1,800% turnover in 15 years

28/09 19:15 Many - 1st half 2015 : Agreement signed on MPG, and significant advances in 100% bio-based L-Methionine

23/09 07:00 Many - Prodways signs a major strategic partnership with the Chinese company Farsoon, one of the global leaders in 3D Printing

22/09 08:00 Many - Half-year results 2015: Strong increase in turnover and EBITDA - Guidance confirmation for 2017: MEUR 120 turnover and MEUR 32 EBITDA

21/09 17:40 Many - Genticel presents first half 2015 financial results, operational progress and outlook

08/09 07:30 Many - US patent granted for use of Genticel's antigen delivery vectors in combination therapy to treat cancer

27/07 18:00 Many - Quantum Genomics announces the appointment of Professor Faiez Zannad as its heart failure consultant

23/07 18:30 Many - Sharp increase in 2014/2015 results

23/07 18:00 Many - H1 2015 REVENUE

30/06 07:00 Many - NATUREX unveils its strategic plan " BRIGHT2020 "

02/06 19:00 Many - TRONICS AIMS TO BENEFIT FROM MAJOR GROWTH IN SENSORS AND RELATED TECHNOLOGIES FOR HEALTHCARE APPLICATIONS

02/06 17:45 Many - Quantum Genomics at the 2015 BIO International Convention, June 15-18 in Philadelphia, and at the French Life Sciences Days, June 17-18, 2015, in New York

01/06 07:00 Many - Genticel Announces Positive Preclinical Proof of Concept Results of GTL002, its New Multivalent HPV Therapeutic Vaccine Candidate Based on Company's Versatile Vaxiclase Platform

19/05 17:30 Many - 2014/2015 revenues of E61.3 million